Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ka Weng Leong

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Cell and Developmental Biology|December 17, 2025
Regulation of the microprocessor by post-translational modificationsKa Weng Leong, Mark M W Chong
Cellular and Molecular Life Sciences : CMLS|December 1, 2022
A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axisJunnan Li, Pengchen Chen, Qiushuang Wu, et al.
International Journal of Biological Sciences|June 21, 2024
Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancerJunnan Li, Yehuda G Assaraf, Weimin Zuo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Cell and Developmental Biology|December 17, 2025
Regulation of the microprocessor by post-translational modificationsKa Weng Leong, Mark M W Chong
Cellular and Molecular Life Sciences : CMLS|December 1, 2022
A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axisJunnan Li, Pengchen Chen, Qiushuang Wu, et al.
International Journal of Biological Sciences|June 21, 2024
Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancerJunnan Li, Yehuda G Assaraf, Weimin Zuo, et al.
Pageof 1